These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33295144)
1. Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target? Ameline B; Kovac M; Nathrath M; Barenboim M; Witt O; Krieg AH; Baumhoer D J Pathol Clin Res; 2021 Mar; 7(2):165-172. PubMed ID: 33295144 [TBL] [Abstract][Full Text] [Related]
2. Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. Behjati S; Tarpey PS; Haase K; Ye H; Young MD; Alexandrov LB; Farndon SJ; Collord G; Wedge DC; Martincorena I; Cooke SL; Davies H; Mifsud W; Lidgren M; Martin S; Latimer C; Maddison M; Butler AP; Teague JW; Pillay N; Shlien A; McDermott U; Futreal PA; Baumhoer D; Zaikova O; Bjerkehagen B; Myklebost O; Amary MF; Tirabosco R; Van Loo P; Stratton MR; Flanagan AM; Campbell PJ Nat Commun; 2017 Jun; 8():15936. PubMed ID: 28643781 [TBL] [Abstract][Full Text] [Related]
3. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines. Luk F; Yu Y; Walsh WR; Yang JL Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050 [TBL] [Abstract][Full Text] [Related]
4. Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma. Taylor AM; Sun JM; Yu A; Voicu H; Shen J; Barkauskas DA; Triche TJ; Gastier-Foster JM; Man TK; Lau CC Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887382 [TBL] [Abstract][Full Text] [Related]
5. [Cytometric analysis of the relation between aneuploidy and expression of receptors for insulin growth factor I in child and adolescent osteosarcoma, after preliminary chemotherapy]. Rytwiński K; Wnuk A; Woźniak W; Rychłowska M Med Wieku Rozwoj; 2004; 8(2 Pt 1):275-81. PubMed ID: 15738603 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma. Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554 [TBL] [Abstract][Full Text] [Related]
8. The possible role of insulin-like growth factor-1 in osteosarcoma. Li YS; Liu Q; He HB; Luo W Curr Probl Cancer; 2019 Jun; 43(3):228-235. PubMed ID: 30217668 [TBL] [Abstract][Full Text] [Related]
9. IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma. Kuijjer ML; Peterse EF; van den Akker BE; Briaire-de Bruijn IH; Serra M; Meza-Zepeda LA; Myklebost O; Hassan AB; Hogendoorn PC; Cleton-Jansen AM BMC Cancer; 2013 May; 13():245. PubMed ID: 23688189 [TBL] [Abstract][Full Text] [Related]
10. Assessment of GSK1904529A as a promising anti-osteosarcoma agent. Fei HD; Yuan Q; Mao L; Chen FL; Cui ZH; Tao S; Ji F Oncotarget; 2017 Jul; 8(30):49646-49654. PubMed ID: 28572530 [TBL] [Abstract][Full Text] [Related]
11. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis. Zhao H; Li M; Li L; Yang X; Lan G; Zhang Y PLoS One; 2013; 8(12):e83571. PubMed ID: 24391788 [TBL] [Abstract][Full Text] [Related]
13. Targeted therapy for osteosarcoma: a review. Li S; Zhang H; Liu J; Shang G J Cancer Res Clin Oncol; 2023 Aug; 149(9):6785-6797. PubMed ID: 36807762 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models. Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma. Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566 [TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for high-grade osteosarcoma. Hattinger CM; Pasello M; Ferrari S; Picci P; Serra M Expert Opin Emerg Drugs; 2010 Dec; 15(4):615-34. PubMed ID: 20690888 [TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma Pathogenesis Leads the Way to New Target Treatments. Fernandes I; Melo-Alvim C; Lopes-Brás R; Esperança-Martins M; Costa L Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467481 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma. Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352 [TBL] [Abstract][Full Text] [Related]
19. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma. Smida J; Baumhoer D; Rosemann M; Walch A; Bielack S; Poremba C; Remberger K; Korsching E; Scheurlen W; Dierkes C; Burdach S; Jundt G; Atkinson MJ; Nathrath M Clin Cancer Res; 2010 Aug; 16(16):4256-67. PubMed ID: 20610556 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma. Cao Y; Roth M; Piperdi S; Montoya K; Sowers R; Rao P; Geller D; Houghton P; Kolb EA; Gill J; Gorlick R PLoS One; 2014; 9(8):e106249. PubMed ID: 25170759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]